ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 15 filers reported holding ANEBULO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,009 | -38.9% | 3,300 | -35.8% | 0.00% | – |
| Q1 2024 | $14,746 | -33.1% | 5,138 | -43.6% | 0.00% | – |
| Q4 2023 | $22,027 | -65.4% | 9,102 | -56.3% | 0.00% | -100.0% |
| Q3 2023 | $63,700 | +344.3% | 20,851 | +241.8% | 0.00% | – |
| Q2 2023 | $14,337 | +95480.0% | 6,101 | +19.5% | 0.00% | – |
| Q1 2023 | $15 | +66.7% | 5,107 | +42.0% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 3,597 | -50.9% | 0.00% | – |
| Q3 2022 | $21,000 | -43.2% | 7,330 | +2.6% | 0.00% | -100.0% |
| Q2 2022 | $37,000 | +640.0% | 7,141 | +844.6% | 0.00% | – |
| Q1 2022 | $5,000 | – | 756 | +1838.5% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 39 | -75.3% | 0.00% | – |
| Q2 2021 | $1,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 3,362,713 | $17,486,000 | 9.28% |
| LVW Advisors, LLC | 700,000 | $3,640,000 | 0.74% |
| Ikarian Capital, LLC | 181,199 | $942,000 | 0.17% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $2,076,000 | 0.10% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,333 | $90,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,141 | $37,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 20 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 2,909 | $15,000 | 0.00% |
| BlackRock Inc. | 7,333 | $38,000 | 0.00% |